Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...

Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...

The agreement as a strategic milestone in Egypt’s efforts to localize pharmaceutical manufacturing and introduce advanced ...

Now, more than half a year later, the expansion plan for one of the company’s new facilities—a former magazine plant in ...

· In return for their investment in U.S. manufacturing, the administration would drop a proposed 100% tariffs on branded and patented drugs imported to the U.S. · Trump’s push for most-favored-nation ...

Regeneron is expanding its pharmaceutical production in New York, joining a wave of drug companies growing domestic ...

Indian generics would soon become the backbone of the global HIV response. Within two years, the US launched PEPFAR, the ...

Despite many overseas drugmakers gaining some tariff clarity when the U.S. | Thanks to a new accord with the United States, ...

Bombay High Court halts Adwin Pharma from selling "ELGIMET" diabetes drugs due to potential confusion with "GLIMET" trademark.

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?

The US pharmaceutical supply chain relies heavily on imports, with roughly 80% of APIs sourced from China and India. 2 Tariffs could raise input costs, trigger retaliatory trade measures, or ...